Renesas Ramps Up Chip Volume to Support First FDA-Authorized At-Home Test for COVID-19
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
The Lucira™ COVID-19 All-In-One Self-Test Kit Delivers Results Within 30 Minutes

Renesas Delivers Power Converter for Lucira Health's At-Home COVID-19 Test Kit (Photo: Business Wire)
Testing is a key weapon in the fight against COVID-19 with over 600 million tests administered in
“We’re particularly pleased to contribute to Lucira’s important COVID-19 self-testing kit,” said
“Delivering the first single-use, at-home, molecular test kit for COVID-19 was a tremendous achievement of which we are extremely proud,” said
Renesas’ Commitment to Fighting COVID-19
Renesas delivers key solutions that are essential in helping society deal with the current pandemic. Healthcare, air purification, air quality monitoring, networking and mobility solutions from Renesas are being employed by customers around the world to enable a “new normal.” More information is available at www.renesas.com/about/press-center/covid-19.
About Lucira Health
Lucira is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. Lucira’s testing platform produces lab quality molecular testing in a single-use, consumer-friendly, palm-size test kit powered by two AA batteries. Lucira designed its test kits to provide accurate, reliable and on-the-spot molecular test results anywhere and at any time. The LUCIRA™ CHECK IT COVID-19 Test Kit (OTC) and LUCIRA™ COVID-19 All-In-One Test Kit (Rx) are designed to provide a clinically relevant COVID-19 result within 30 minutes from sample collection. For more information, visit www.lucirahealth.com.
About
All names of products or services mentioned in this press release are trademarks or registered trademarks of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211102005467/en/
+ 1-408-887-4308
don.parkman.xh@renesas.com
Lucira Health
investorrelations@lucirahealth.com
347-620-7010
Source: